169 related articles for article (PubMed ID: 33058882)
1. Gene Expression of Disease-related Genes in Alzheimer's Disease is Impaired by Tau Aggregation.
Siano G; Varisco M; Scarlatti A; Caiazza MC; Dunville K; Cremisi F; Costa M; Pancrazi L; Di Primio C; Cattaneo A
J Mol Biol; 2020 Dec; 432(24):166675. PubMed ID: 33058882
[TBL] [Abstract][Full Text] [Related]
2. Tau Modulates VGluT1 Expression.
Siano G; Varisco M; Caiazza MC; Quercioli V; Mainardi M; Ippolito C; Cattaneo A; Di Primio C
J Mol Biol; 2019 Feb; 431(4):873-884. PubMed ID: 30664870
[TBL] [Abstract][Full Text] [Related]
3. Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation.
Wojtas AM; Carlomagno Y; Sens JP; Kang SS; Jensen TD; Kurti A; Baker KE; Berry TJ; Phillips VR; Castanedes MC; Awan A; DeTure M; De Castro CHF; Librero AL; Yue M; Daughrity L; Jansen-West KR; Cook CN; Dickson DW; Petrucelli L; Fryer JD
Acta Neuropathol Commun; 2020 Dec; 8(1):210. PubMed ID: 33261653
[TBL] [Abstract][Full Text] [Related]
4. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein.
Nieznanska H; Boyko S; Dec R; Redowicz MJ; Dzwolak W; Nieznanski K
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166209. PubMed ID: 34246750
[TBL] [Abstract][Full Text] [Related]
6. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
7. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
[TBL] [Abstract][Full Text] [Related]
8. TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease.
Zhang ZY; Harischandra DS; Wang R; Ghaisas S; Zhao JY; McMonagle TP; Zhu G; Lacuarta KD; Song J; Trojanowski JQ; Xu H; Lee VM; Yang X
Science; 2023 Jul; 381(6656):eadd6696. PubMed ID: 37499037
[TBL] [Abstract][Full Text] [Related]
9. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
Kim E; Sakata K; Liao FF
PLoS Genet; 2017 Jul; 13(7):e1006849. PubMed ID: 28678786
[TBL] [Abstract][Full Text] [Related]
11. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
12. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
Annadurai N; De Sanctis JB; Hajdúch M; Das V
Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice.
Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA
Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665
[TBL] [Abstract][Full Text] [Related]
14. Synaptic Localisation of Tau.
Hanger DP; Goniotaki D; Noble W
Adv Exp Med Biol; 2019; 1184():105-112. PubMed ID: 32096032
[TBL] [Abstract][Full Text] [Related]
15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
16. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
[TBL] [Abstract][Full Text] [Related]
17. Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression.
Hunsberger HC; Weitzner DS; Rudy CC; Hickman JE; Libell EM; Speer RR; Gerhardt GA; Reed MN
J Neurochem; 2015 Oct; 135(2):381-94. PubMed ID: 26146790
[TBL] [Abstract][Full Text] [Related]
18. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
Mocanu MM; Nissen A; Eckermann K; Khlistunova I; Biernat J; Drexler D; Petrova O; Schönig K; Bujard H; Mandelkow E; Zhou L; Rune G; Mandelkow EM
J Neurosci; 2008 Jan; 28(3):737-48. PubMed ID: 18199773
[TBL] [Abstract][Full Text] [Related]
19. PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo.
Okuda M; Hijikuro I; Fujita Y; Wu X; Nakayama S; Sakata Y; Noguchi Y; Ogo M; Akasofu S; Ito Y; Soeda Y; Tsuchiya N; Tanaka N; Takahashi T; Sugimoto H
PLoS One; 2015; 10(2):e0117511. PubMed ID: 25659102
[TBL] [Abstract][Full Text] [Related]
20. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
